{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:57:20Z","timestamp":1781463440257,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme United Kingdom","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijid.2026.108715","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:44:23Z","timestamp":1776408263000},"page":"108715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Incidence of human papillomavirus infections in women aged 27 years and older in the US: A federated data network study"],"prefix":"10.1016","volume":"168","author":[{"given":"Ellen","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Peer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Tota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuedan","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Arnold","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Niccolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108715_bib0001","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/OLQ.0000000000001356","article-title":"Estimated prevalence and incidence of disease-associated human papillomavirus types among 15- to 59-year-olds in the United States","volume":"48","author":"Lewis","year":"2021","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ijid.2026.108715_bib0002","doi-asserted-by":"crossref","first-page":"698","DOI":"10.15585\/mmwr.mm6832a3","article-title":"Human papillomavirus vaccination for adults: updated recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Meites","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2026.108715_bib0003","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijid.2026.108715_bib0004","series-title":"Clinical overview of HPV","year":"2024"},{"key":"10.1016\/j.ijid.2026.108715_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.2530","article-title":"Trends in human papillomavirus-associated cancers, demographic characteristics, and vaccinations in the US, 2001\u20132017","volume":"5","author":"Liao","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijid.2026.108715_bib0006","doi-asserted-by":"crossref","first-page":"337","DOI":"10.15585\/mmwr.mm6815a1","article-title":"Estimated number of cases of high-grade cervical lesions diagnosed among women - United States, 2008 and 2016","volume":"68","author":"McClung","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2026.108715_bib0007","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.vaccine.2023.02.049","article-title":"Updated estimate of the annual direct medical cost of screening and treatment for human papillomavirus associated disease in the United States","volume":"41","author":"Clay","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108715_bib0008","series-title":"Epidemiology and prevention of vaccine-preventable diseases","author":"Hall","year":"2021"},{"key":"10.1016\/j.ijid.2026.108715_bib0009","series-title":"Prescribing information [package insert]. Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant)","year":"2018"},{"key":"10.1016\/j.ijid.2026.108715_bib0010","series-title":"Human Papillomavirus (HPV) Vaccine Information Health Care Provider 2021","year":"2021"},{"key":"10.1016\/j.ijid.2026.108715_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003534","article-title":"Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: a cost-effectiveness analysis","volume":"18","author":"Kim","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2026.108715_bib0012","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.acap.2017.09.014","article-title":"Ten years of human papillomavirus vaccination in the United States","volume":"18","author":"Markowitz","year":"2018","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.ijid.2026.108715_bib0013","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjos\u00e9","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.108715_bib0014","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/ijc.22241","article-title":"Variations in the age-specific curves of human papillomavirus prevalence in women worldwide","volume":"119","author":"Franceschi","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijid.2026.108715_bib0015","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1093\/eurpub\/ckae075","article-title":"Understanding the high-risk human papillomavirus prevalence and associated factors in the European country with a high incidence of cervical cancer","volume":"34","author":"Berza","year":"2024","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.ijid.2026.108715_bib0016","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/infdis\/jiad043","article-title":"Human papillomavirus intermittence and risk factors associated with first detections and Redetections in the ludwig-McGill cohort study of adult women","volume":"228","author":"Malag\u00f3n","year":"2023","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.108715_bib0017","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/infdis\/jix655","article-title":"Prevalence of Genital Human papillomavirus among sexually experienced males and females aged 14\u201359 years, United States, 2013\u20132014","volume":"217","author":"Lewis","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.108715_bib0018","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1086\/425280","article-title":"Social context, sexual networks, and racial disparities in rates of sexually transmitted infections","volume":"191","author":"Adimora","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.108715_bib0019","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1200\/JCO.22.01424","article-title":"Racial and ethnic disparities in cervical cancer incidence, survival, and mortality by histologic subtype","volume":"41","author":"Cohen","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijid.2026.108715_bib0020","first-page":"464","article-title":"Cancer screening test use - United States, 2013","volume":"64","author":"Sabatino","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2026.108715_bib0021","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ygyno.2019.03.253","article-title":"Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population","volume":"154","author":"Giuliano","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijid.2026.108715_bib0022","doi-asserted-by":"crossref","first-page":"f5906","DOI":"10.1136\/bmj.f5906","article-title":"Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study","volume":"347","author":"Arnheim-Dahlstr\u00f6m","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2026.108715_bib0023","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1808","article-title":"Near real-time surveillance to assess the safety of the 9-valent human papillomavirus vaccine","volume":"144","author":"Donahue","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijid.2026.108715_bib0024","doi-asserted-by":"crossref","first-page":"8279","DOI":"10.1016\/j.vaccine.2011.08.106","article-title":"Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the vaccine Safety Datalink","volume":"29","author":"Gee","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108715_bib0025","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.vaccine.2023.02.051","article-title":"Health care provider knowledge around shared clinical decision-making regarding HPV vaccination of adults aged 27\u201345 years in the United States","volume":"41","author":"Gidengil","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.ijid.2026.108715_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/pds.70198","article-title":"TriNetX Dataworks-USA: overview of a multi-purpose, de-identified, federated electronic health record real-world data and analytics network and comparison to the US census","volume":"34","author":"Stein","year":"2025","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ijid.2026.108715_bib0027","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1128\/CMR.00013-15","article-title":"Human papillomavirus laboratory testing: the changing paradigm","volume":"29","author":"Burd","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijid.2026.108715_bib0028","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical cancer: US Preventive Services Task Force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2026.108715_bib0029","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/ijc.29143","article-title":"Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection","volume":"136","author":"Gage","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijid.2026.108715_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/pds.70028","article-title":"The FDA sentinel Real World Evidence Data Enterprise (RWE-DE)","volume":"33","author":"Desai","year":"2024","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226003504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226003504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:20:34Z","timestamp":1781461234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226003504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":30,"alternative-id":["S1201971226003504"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108715","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of human papillomavirus infections in women aged 27 years and older in the US: A federated data network study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108715"}}